Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2025-12-25 @ 12:35 AM
NCT ID:
NCT02329067
Eligibility Criteria:
Inclusion Criteria:
* Postmenopausal healthy women and healthy men
* Age \>50 yrs
* Written informed consent prior to study participation
Exclusion Criteria:
* Known allergy to nuts
* Evidence of alcohol (women \>70g/week, men \>140g/week), tabacco or drug abuse
* Obesity ≥35 kg/m2
* Diabetes mellitus
* Hypertension \>140/90 mmHg or history of hypertension
* LDL-cholesterol \>190 mg/dl, Triglycerides \> 350 mg/dl
* History of atherosclerotic disease
* Liver disease of any etiology
* Kidney disease of any etiology (GFR \< 60 ml/min/1.73)
* Uncontrolled thyroid disease or other endocrine diseases
* Acute or chronic inflammatory diseases
* Active malignancy
* Current or previous (within 3 months) treatment with antidiabetic drugs, hypolipidemic drugs, antihypertensive drugs, anti-inflammatory drugs, vitamin E, hormonal replacement therapy
* major surgical intervention within 3 months (or planned)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT02329067
Study Brief:
Protocol Section:
NCT02329067